Last viewed: QGEN

Prices are updated after-hours

QGEN Nasdaq 2020 - 10 - 13

Qiagen N.V.

QGEN | $39.31 -0.91% 240K

|

Health Technology

(0.0% 1d) (-10.1% 1m) (-14.1% 1y) (0.0% 2d) (0.0% 3d) (-3.7% 7d) (-14.09% volume)
Earnings Calendar:
Market Cap: $ 8,970,650,299
http://www.qiagen.com
Sec Filling | Patents | 5096 employees

(NL) QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

genomic molecular diagnostics diagnostics

add to watch list Paper trade email alert is off

Press-releases

QIAGEN N.V. to release results for Q1 2024 and hold webcast
Published: 2024-04-09 (Crawled : 14:00) - globenewswire.com
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -4.41% | O: -0.41% H: 1.57% C: 1.55%
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -4.41% | O: -0.41% H: 1.57% C: 1.55%
for results

QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
Published: 2024-04-03 (Crawled : 20:00) - globenewswire.com
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -5.34% | O: -1.05% H: 0.8% C: -0.87%
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -5.34% | O: -1.05% H: 0.8% C: -0.87%
cancer meeting

DNA Methylation Detection Technology Markets, 2033 - Intensified Competition, Increasing Adoption, PCR Dominates
Published: 2024-03-30 (Crawled : 04:20) - prnewswire.com
ABCM | $23.99 0.0% 7.4M

|

Health Technology

| Email alert Add to watchlist
EXAS | $64.425 -1.42% 1.3M

|

Health Technology

| Email alert Add to watchlist
HOLX | $75.77 -2.28% 250K

|

Health Technology

| Email alert Add to watchlist
ILMN | $117.87 -2.72% 630K

|

Health Technology

| Email alert Add to watchlist
PACB | $1.525 -46.21% 30M

|

Health Technology

| Email alert Add to watchlist
QGEN | $39.31 -0.91% 240K

|

Health Technology

| Email alert Add to watchlist
A | $136.83 -2.42% 330K

|

Health Technology

| Email alert Add to watchlist
BIO | $297.17 -1.08% 18K

|

Health Technology

| Email alert Add to watchlist
PKI | $115.24 0.0% 1.6M

|

Health Technology

| Email alert Add to watchlist
QGEN | $39.31 -0.91% 240K

|

Health Technology

| Email alert Add to watchlist
ABCZF | $22.1 -2.32% 4K

|

Health Technology

| Email alert Add to watchlist
dna technology

Global Sample Preparation Market Analysis and Outlook 2023-2030 Featuring Profiles of Agilent Technologies, Bio-Rad Labs, Danaher Corp, Illumina, Merck, and Other Key Players
Published: 2024-03-29 (Crawled : 11:00) - prnewswire.com
ILMN | $117.87 -2.72% 630K

|

Health Technology

| Email alert Add to watchlist
QGEN | $39.31 -0.91% 240K

|

Health Technology

| Email alert Add to watchlist
A | $136.83 -2.42% 330K

|

Health Technology

| Email alert Add to watchlist
BIO | $297.17 -1.08% 18K

|

Health Technology

| Email alert Add to watchlist
DHR | $239.31 -0.15% 660K

|

Health Technology

| Email alert Add to watchlist
PKI | $115.24 0.0% 1.6M

|

Health Technology

| Email alert Add to watchlist
QGEN | $39.31 -0.91% 240K

|

Health Technology

| Email alert Add to watchlist
TMO | $553.21 -0.84% 250K

|

Health Technology

| Email alert Add to watchlist
global key market

In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets™
Published: 2024-03-27 (Crawled : 14:30) - prnewswire.com
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -7.1% | O: 0.02% H: 0.28% C: 0.09%
DHR | $239.31 -0.15% 660K

|

Health Technology

| -3.54% | O: 0.56% H: 0.16% C: -0.43%
BIO | $297.17 -1.08% 18K

|

Health Technology

| -11.78% | O: 0.62% H: 2.18% C: 2.02%
BDX | $232.67 -0.87% 180K

|

Health Technology

| -2.96% | O: 0.57% H: 1.36% C: 1.34%
A | $136.83 -2.42% 330K

|

Health Technology

| -2.9% | O: 0.86% H: 1.26% C: 1.18%
ABT | $109.02 0.12% 1.7M

|

Health Technology

| -1.4% | O: 1.48% H: 0.0% C: 0.0%
SRDX | $26.245 -2.8% 2.6K

|

Health Technology

| -6.35% | O: 0.99% H: 2.11% C: 1.09%
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -7.1% | O: 0.02% H: 0.28% C: 0.09%
ILMN | $117.87 -2.72% 630K

|

Health Technology

| -4.5% | O: 1.28% H: 2.34% C: 2.34%
HOLX | $75.77 -2.28% 250K

|

Health Technology

| 1.8% | O: 0.56% H: 1.01% C: 0.98%
AXDX M | $0.91 4.1K

|

Health Technology

| -5.24% | O: 4.13% H: 1.0% C: 1.0%
diagnostics market

QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
Published: 2024-03-25 (Crawled : 20:00) - globenewswire.com
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -7.36% | O: -1.59% H: 1.33% C: 1.33%
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -7.36% | O: -1.59% H: 1.33% C: 1.33%
test system collaboration results

DNA Sequencing Market Projected to Reach $210.34 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-03-22 (Crawled : 01:00) - prnewswire.com
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -9.18% | O: 0.34% H: 0.05% C: 0.05%
BIO | $297.17 -1.08% 18K

|

Health Technology

| -14.65% | O: 0.59% H: 1.71% C: -1.02%
A | $136.83 -2.42% 330K

|

Health Technology

| -5.54% | O: 0.27% H: 0.29% C: -0.94%
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -9.18% | O: 0.34% H: 0.05% C: 0.05%
ILMN | $117.87 -2.72% 630K

|

Health Technology

| -7.03% | O: -0.31% H: 0.34% C: 0.16%
report reach dna market

QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
Published: 2024-03-18 (Crawled : 20:00) - globenewswire.com
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -10.13% | O: 0.18% H: 0.3% C: -0.47%
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -10.13% | O: 0.18% H: 0.3% C: -0.47%
association international

Europe Biomanufacturing Viral Detection and Quantification Research Report 2023-2032: Research Initiatives to Enhance the Accuracy, Efficiency, and Accessibility of Viral Testing Assays
Published: 2024-03-14 (Crawled : 22:00) - prnewswire.com
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -9.88% | O: -0.25% H: 0.57% C: 0.3%
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -9.88% | O: -0.25% H: 0.57% C: 0.3%
europe report research

QIAGEN announces Form 20-F annual report filing for 2023 results
Published: 2024-03-11 (Crawled : 10:00) - globenewswire.com
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -10.77% | O: 0.52% H: 0.83% C: 0.74%
QGEN | $39.31 -0.91% 240K

|

Health Technology

| -10.77% | O: 0.52% H: 0.83% C: 0.74%
report results

See all

Last 15 days Sec forms

File Id

Form

Published Date

Transaction Date

Direction

Code

Amount Transacted

Owned Amount

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

50%

50%

Top 10 Gainers

TPET | $0.503 117.66% 21M

|

WISA 4 | $3.22 84.0% 56M

|

Electronic Technology

SXTC | $2.56 82.86% 11M

|

Health Technology

PRSO | $1.99 56.69% 52M

|

PALI | $6.5 56.25% 22M

|

JAGX | $0.1767 48.74% 430M

|

Health Technology

DYNT | $0.5255 41.87% 18M

|

Health Technology

MCBC | $13.795 38.92% 820K

|

BTTR | $6.86 34.51% 5.2M

|

SNGX | $0.51 32.09% 6.3M

|

Health Technology

Last 48 Hours Insiders Buying

HNRA | $2.65 12.29% 220K

|

| 15:02
TGEN | $0.67 16K

|

| 14:30
RMCF | $3.6492 3.8K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar